Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 gene

Stem Cell Res. 2022 Aug:63:102829. doi: 10.1016/j.scr.2022.102829. Epub 2022 Jun 6.

Abstract

Variants in the ACTA1 gene are a common cause of nemaline myopathy (NM); a muscle disease that typically presents at birth or early childhood with hypotonia and muscle weakness. Here, we generated an induced pluripotent stem cell line (iPSC) from lymphoblastoid cells of a 3-month-old female patient with intermediate NM caused by a dominant ACTA1 variant (c.515C > A (p.Ala172Glu)). iPSCs showed typical morphology, expressed pluripotency markers, demonstrated trilineage differentiation potential, and had a normal karyotype. This line complements our previously published ACTA1 iPSC lines derived from patients with typical and severe NM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / genetics
  • Actins / metabolism
  • Child, Preschool
  • Female
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Infant
  • Infant, Newborn
  • Muscle, Skeletal / metabolism
  • Mutation
  • Myopathies, Nemaline* / genetics

Substances

  • Actins